riboflavin 5-phosphate ophthalmic

FDA Drug Profile — Photrexa Cross-linking Kit, EPIOXA CROSS-LINKING

riboflavin 5-phosphate ophthalmic is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Photrexa Cross-linking Kit, EPIOXA CROSS-LINKING. Available dosage form: kit.

Drug details

Generic Name
riboflavin 5-phosphate ophthalmic
Brand Names
Photrexa Cross-linking Kit, EPIOXA CROSS-LINKING
Application Number
NDA203324
Sponsor
Glaukos Corporation
NDC Codes
3
Dosage Forms
KIT
Routes
OPHTHALMIC

Indications and Usage

1 INDICATIONS AND USAGE PHOTREXA ® VISCOUS and PHOTREXA ® are indicated for use in corneal collagen cross-linking in combination with the KXL ® System for the treatment of PHOTREXA VISCOUS and PHOTREXA are photoenhancers indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus ( 1.1 ) and corneal ectasia following refractive surgery ( 1.2 ). 1.1 Progressive Keratoconus 1.2 Corneal Ectasia Following Refractive Surgery

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.